Literature DB >> 16735493

Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes.

Vivian Sobel1, Brian Schwartz, Yuan-Shan Zhu, Juan J Cordero, Julianne Imperato-McGinley.   

Abstract

CONTEXT: Subjects with complete androgen insensitivity (CAI) and 5alpha-reductase-2 deficiency (5alphaRD-2) are natural human models to study the direct effect of androgens on bone mineral density (BMD).
OBJECTIVE: The objective of this study was to test the hypothesis that androgens have a direct effect on BMD in men.
DESIGN: This was a prospective, observational study (1989-1999) using dual energy x-ray absorptiometry.
SETTING: The study was set in an outpatient specialty referral center. PATIENTS OR OTHER PARTICIPANTS: All known subjects with these conditions (12 CAI and 16 5alphaRD-2) from diverse sociodemographic backgrounds were recruited for the study.
INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURE: Mean Z score and weight-matched Z score at lumbar spine and femoral neck for CAI and 5alphaRD-2 subjects were determined.
RESULTS: Twelve CAI subjects had mean Z score at L2-L4 of -2.84 (+/-0.97, P < 0.001) and a mean weight-matched Z score of -2.52 (+/-0.94, P < 0.001). The mean Z score at the femoral neck was -1.33 (+/-0.91, P < 0.001) and the mean weight-matched Z score was -1.10 (+/-0.82, P = 0.001). Sixteen 5alphaRD-2 subjects had a mean Z score at L2-L4 of -0.84 (+/-1.29, P = 0.02) and a mean weight-matched Z score for 15 of 16 patients of -0.44 (+/-1.08, P = 0.14). The mean Z score at the femoral neck was 0.14 (+/-1.02, P = 0.58) and the mean weight-matched Z score for 15 of 16 patients was 0.49 (+/-0.94, P = 0.06). Therefore, in CAI subjects, BMD was significantly decreased in the spine and hip. 5alphaRD-2 subjects had normal BMD values.
CONCLUSIONS: 1) Androgens are of direct importance in the development and/or maintenance of BMD; and 2) testosterone and/or low levels of dihydrotestosterone appear to be sufficient for BMD development and/or maintenance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735493     DOI: 10.1210/jc.2005-2809

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Battle of the sex steroids in the male skeleton: and the winner is....

Authors:  Thomas J Weber
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

2.  Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.

Authors:  G Tirabassi; N delli Muti; A Gioia; A Biagioli; A Lenzi; G Balercia
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

Review 3.  Bone Remodeling and the Microbiome.

Authors:  Roberto Pacifici
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 4.  Estrogens in Male Physiology.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; CheMyong Ko; Gail S Prins; Rex A Hess
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

5.  Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.

Authors:  Shalender Bhasin; Thomas G Travison; Thomas W Storer; Kishore Lakshman; Manas Kaushik; Norman A Mazer; Ahn-Hoa Ngyuen; Maithili N Davda; Hernan Jara; Adam Aakil; Stephan Anderson; Philip E Knapp; Samson Hanka; Nurahmed Mohammed; Pierre Daou; Renee Miciek; Jagadish Ulloor; Anqi Zhang; Brad Brooks; Katie Orwoll; Leife Hede-Brierley; Richard Eder; Ayan Elmi; Geeta Bhasin; Lauren Collins; Ravinder Singh; Shehzad Basaria
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

6.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

7.  Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene.

Authors:  D L S Danilovic; P H S Correa; E M F Costa; K F S Melo; B B Mendonca; I J P Arnhold
Journal:  Osteoporos Int       Date:  2006-11-01       Impact factor: 4.507

8.  Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase.

Authors:  Barbara J Attardi; Trung C Pham; Lisa C Radler; Janet Burgenson; Sheri A Hild; Jerry R Reel
Journal:  J Steroid Biochem Mol Biol       Date:  2008-06       Impact factor: 4.292

9.  Role of imaging in the diagnosis and management of complete androgen insensitivity syndrome in adults.

Authors:  Marco Nezzo; Pieter De Visschere; Guy T'sjoen; Steven Weyers; Geert Villeirs
Journal:  Case Rep Radiol       Date:  2013-05-23

10.  46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome, 5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes.

Authors:  Amy B Wisniewski; Tom Mazur
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.